Manufacturing and Production
Consortium wins US biodefence contract
April 3, 2009 Manufacturing and Production biologics, vaccines
A consortium of US and UK companies has been awarded an $11 million grant from the US Government to speed …
Bayer Schering Pharma restricts UK distribution
April 2, 2009 Manufacturing and Production Bayer
Bayer Schering Pharma has joined the ranks of firms switching to restrictive distribution arrangements in the UK. The pharma company, …
Patients to get counterfeit warning with each prescription
March 31, 2009 Manufacturing and Production counterfeits
New guidance to patients to raise public awareness of fake medicine and its dangers has been launched by the RPSGB …
Merck hikes investment in Irish biologics plant
March 30, 2009 Manufacturing and Production Europe, Ireland
Merck & Co has increased its investment in a new biologic and vaccines facility in Carlow, Ireland, to 220 million …
Small and flexible: the manufacturing of tomorrow
March 24, 2009 Manufacturing and Production biologics
Biopharmaceutical manufacturing is likely to undergo a dramatic change over the next 20 years, with the today's facilities facing dramatic …
Mannkind picks up Pfizer’s Exubera facility
March 16, 2009 Manufacturing and Production Mannkind, diabetes
The demise of Pfizer's inhaled diabetes treatment Exubera cast a pall over the prospects for inhaled insulin therapy, but has …
Are biosimilars delivering the goods in the EU?
March 10, 2009 Manufacturing and Production, Research and Development biosimilars
In January, leading pharmaceutical experts attended the 2009 Forum Institute seminar on biosimilars, and the challenges involved in their successful …
UCB plans new Belgian biomanufacturing plant
March 6, 2009 Manufacturing and Production UCB
Belgian biopharmaceutical company UCB has earmarked euros 65 million for the construction of its first biologics manufacturing plant in Braine-l'Alleud. …
FDA puts block on Ranbaxy products
March 4, 2009 Manufacturing and Production Ranbaxy
India’s Ranbaxy Laboratories has been dealt another blow by the FDA after the agency suspended regulatory review of any products …
Contract manufacturing could profit from downturn
March 2, 2009 Manufacturing and Production Kalorama
The market for contract manufacturing of prescription drugs exceeded $30 billion last year, a 10% increase that is being fuelled …
Novartis vaccine recalled after contamination scare
February 26, 2009 Manufacturing and Production, Research and Development Vaccine
Novartis has recalled UK supplies of its meningitis C vaccine after tests found some batches contaminated with bacteria. The recall …
Chinese contract manufacturers to benefit from downturn
February 2, 2009 Manufacturing and Production CMO, China
China's contract manufacturing organisation market was valued at more than $70 billion in 2007, with pharmaceuticals comfortably the largest contributor, …
